FibroBiologics, Inc.
A clinical-stage biotech developing fibroblast cell-based therapies for chronic diseases.
FBLG | US
Overview
Corporate Details
- ISIN(s):
- US31573L1052
- LEI:
- Country:
- United States of America
- Address:
- 455 E. MEDICAL CENTER BLVD, 77598 HOUSTON
- Website:
- https://fibrobiologics.com/
- Sector:
- Manufacturing
Description
FibroBiologics, Inc. is a clinical-stage biotechnology company focused on developing fibroblast cell-based therapies for chronic diseases. The company utilizes the regenerative and immune-modulating properties of fibroblasts, the primary cell type in connective tissue, to create treatments for conditions where there is a significant unmet medical need. Its development pipeline targets multiple sclerosis, degenerative disc disease, and wound healing. FibroBiologics is also advancing a bone marrow organoid platform for potential applications in cancer and immune-related therapies. The company's research and development are supported by an intellectual property portfolio of over 160 issued patents.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all FibroBiologics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for FibroBiologics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for FibroBiologics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
